ACRS Q3 2018 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ACRSAclaris Therapeutics, Inc.

$407M

Q3 2018 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$2M+138.0% YoY

Gross Profit

$435,00026.7% margin

Operating Income

-$33M-2054.7% margin

Net Income

-$33M-2011.1% margin

EPS (Diluted)

$-1.06

QoQ Revenue Growth

-55.7%

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$30M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$176M

Total Liabilities

$30M

Stockholders' Equity

$146M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$684,000	+138.0%
Gross Profit	$435,000	$231,000	+88.3%
Operating Income	-$33M	-$19M	-78.3%
Net Income	-$33M	-$18M	-80.0%

Revenue Segments

Laboratory Research Revenue

$1M69%

Product

$510,00031%